A phase 2, double-blind, placebo-controlled, multi-center, randomized study evaluating the safety and efficacy of SPRC-AB01, tobramycin solution for nasal inhalation, in post-surgical subjects with chronic sinusitis
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 27 Nov 2007
At a glance
- Drugs Tobramycin (Primary)
- Indications Bacterial infections; Chronic sinusitis
- Focus Therapeutic Use
- Sponsors Naryx Pharma
- 27 Nov 2007 Patient enrolment completed.
- 26 Nov 2007 Results expected after unblinding of data in first quarter of 2008.
- 26 Nov 2007 Status changed from recruiting to in progress.